Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Healthtrust
Merck
US Department of Justice
Fuji
Cerilliant
Medtronic
Express Scripts
Citi

Generated: June 18, 2018

DrugPatentWatch Database Preview

BUSPIRONE HYDROCHLORIDE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Buspirone Hydrochloride patents expire, and what generic alternatives are available?

Buspirone Hydrochloride is a drug marketed by Accord Hlthcare, Amneal Pharms Co, Apotex, Aurobindo Pharma Ltd, Egis, Fosun Pharma, Heritage Pharma, Impax Labs Inc, Inventia Hlthcare, Ivax Sub Teva Pharms, Mylan, Nesher Pharms, Orion Corp Orion, Oxford Pharms, Strides Pharma, Teva, and Zydus Pharms Usa Inc. and is included in nineteen NDAs.

The generic ingredient in BUSPIRONE HYDROCHLORIDE is buspirone hydrochloride. There are eighteen drug master file entries for this compound. Fifty suppliers are listed for this compound. Additional details are available on the buspirone hydrochloride profile page.
Drug patent expirations by year for BUSPIRONE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for BUSPIRONE HYDROCHLORIDE
Synonyms for BUSPIRONE HYDROCHLORIDE
1-[4-(7,9-dioxo-8-azaspiro[4.5]decan-8-yl)butyl]-4-(pyrimidin-2-yl)piperazin-1-ium chloride
1,1-Cyclopentanediacetimide, N-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-, hydrochloride
207LT9J9OC
33386-08-2
8-(4-(4-(2-Pyrimidinyl)-1-piperazinyl)butyl)-8-azaspiro(4.5)decane-7,9-dione hydrochloride
8-(4-(4-(2-Pyrimidinyl)-1-piperazinyl)butyl)-8-azaspiro(4.5)decane-7,9-dione monohydrochloride
8-(4-(4-(pyrimidin-2-yl)piperazin-1-yl)butyl)-8-azaspiro[4.5]decane-7,9-dione hydrochloride
8-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-8-azaspiro[4.5]decane-7,9-dione hydrochloride
8-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-8-azaspiro[4.5]decane-7,9-dione;hydrochloride
8-[4-(4-pyrimidin-2-ylpiperazinyl)butyl]-8-azaspiro[4.5]decane-7,9-dione, chlo ride
8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9-dione
8-[4-[4-(2-Pyrimidinyl)-1-pipirazinyl]butyl]-8-azaspiro[4,5]decane-7,9-dione hydrochloride
8-[4-[4-(pyrimidine-2-yl)-piperazine-1-yl]-butyl]-8-aza-spiro[4.5]decane-7,9-dione hydrochloride
8-{4-[4-(pyrimidin-2-yl)piperazin-1-yl]butyl}-8-azaspiro[4.5]decane-7,9-dione hydrochloride
8-Azaspiro(4,5)decane-7,9-dione, 8-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-, monohydrochloride
8-Azaspiro(4,5)decane-7,9-dione,8-(4-(4-(2-pyrimidinyl)piperizinyl)butyl)
8-Azaspiro(4.5)decane-7,9-dione, 8-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-,monohydrochloride
8-Azaspiro[4.5]decane-7, 8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-, monohydrochloride
AC-1905
AC1L1VQO
AC1Q3EKR
AKOS015962019
AN-14507
Ansitec
Anxinil
Anxiolan
APC-6002
APC-6003
Apo-Buspirone
B 7148
Barpil
BC228667
Bespar
Biron
Busirone
Buspar
Buspar (TN)
Buspimen
Buspinol
Buspirone (hydrochloride)
Buspirone for system suitability, European Pharmacopoeia (EP) Reference Standard
Buspirone HCL
Buspirone hydrochloride (USP)
Buspirone hydrochloride [USAN:USP]
Buspirone hydrochloride [USAN]
Buspirone Hydrochloride 1.0 mg/ml in Methanol (as free base)
Buspirone hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material
Buspirone hydrochloride, European Pharmacopoeia (EP) Reference Standard
Buspirone hydrochloride, United States Pharmacopeia (USP) Reference Standard
C21H31N5O2.HCl
C21H32ClN5O2
CCG-213652
Censpar
CHEBI:3224
CHEMBL1200399
CPD000058186
CS-4714
CTK8F8364
D00702
DTXSID1037193
Effiplen
EINECS 251-489-4
Establix
EU-0100223
FT-0623290
H05B847
HMS1569I19
HY-B1115
Itagil
J10144
Jsp006125
K-7699
Kallmiren
KS-000018A2
KS-5163
LP00223
LS-22724
Lucelan
Mabuson
MCULE-3504513666
MFCD00078569
MJ 9022-1
MLS000069796
MLS001076085
MLS002548862
MolPort-002-163-732
N-(4-(4-(2-Pyrimidinyl)-1-piperazinyl)butyl)-1,1-cyclopentanediacetamide monohydrochloride
N-[4-(4-[2-Pyrimidinyl]-1-piperazinyl)butyl]-8-azaspiro[4, 5]decane-7, 9-dione
N-[4-[4-(2-Pyrimidinyl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9-dione hydrochloride
Narol
NC00673
NCGC00093692-01
NCGC00093692-02
NCGC00260908-01
Nerbet
Normaton
NSC-751138
NSC-759571
NSC751138
NSC759571
Opera_ID_707
Pharmakon1600-02300173
Prestwick_711
Q-200768
Relac
RICLFGYGYQXUFH-UHFFFAOYSA-N
s4256
SAM002264597
Sburol
SCHEMBL41495
SMR000058186
Spamilan
SR-01000075541
SR-01000075541-1
ST51014924
Tox21_500223
Travin
Tutran
UNII-207LT9J9OC
VA10444

US Patents and Regulatory Information for BUSPIRONE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan BUSPIRONE HYDROCHLORIDE buspirone hydrochloride TABLET;ORAL 075467-002 Mar 28, 2001 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Inventia Hlthcare BUSPIRONE HYDROCHLORIDE buspirone hydrochloride TABLET;ORAL 209696-002 May 3, 2018 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Nesher Pharms BUSPIRONE HYDROCHLORIDE buspirone hydrochloride TABLET;ORAL 075572-002 Feb 27, 2002 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Strides Pharma BUSPIRONE HYDROCHLORIDE buspirone hydrochloride TABLET;ORAL 202330-005 Feb 17, 2017 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Fuji
Johnson and Johnson
Medtronic
Boehringer Ingelheim
Citi
Chinese Patent Office
Dow
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.